You are invited to attend The BioDefense Briefing, the second briefing of The BioDefense Briefing Series, scheduled from 8:00 - 11:00 a.m. on Wednesday, December 15, at the National Press Club in Washington.
Register now - space is limited for this very popular Briefing. The registration fee for the December 15 Briefing is $275 (complimentary for government officials, active military, and diplomats). Take advantage of a discounted registration rate of $175 by registering before December 3.
The Briefing will provide you with the latest information on the fast developing multi-billion-dollar BioDefense Industry, including programs and funding for 2005 and details on BioShield I and II. Sponsors include McKenna Long & Aldridge, The Federal Market Group, Chimerix, GSN, HSToday, and Domestic Preparedness.com, among others
Confirmed speakers include
Colonel Joseph Palma Medical Director
Chemical and Biological Defense Program
Office of the Secretary of Defense
Major General Lester Martinez-Lopez Commanding General
U.S. Army Medical Research
and Materiel Command
Dr. Peter Jutro Deputy Director
National Homeland Security Research Center
Environmental Protection Agency
Chuck Ludlam Counsel
Office of Senator Joseph Lieberman
Frank Rapoport Partner
McKenna Long & Aldridge
John Clerici Partner
McKenna Long & Aldridge
Dan Jacobs Chairman/CEO
The Federal Market Group
Equity International hosted the first BioDefense Briefing on June 21, 2004. It was attended by more than 100 industry and government leaders, including senior officials from The White House, Office of the Secretary of Defense, Congress, Department of Homeland Security, and other health-related federal agencies. More than 7,000 government and industry leaders have participated in the homeland security forums of Equity International, including Secretary Tom Ridge.
Registration Fees
Corporate
$275 ($175 until Dec 3)
Govt Employees/Active Military/Diplomats
Complimentary
To register click here. We accept Visa, MasterCard, and American Express.
The BioDefense Briefing Series features the premier forums in the United States on opportunities in the emerging multi-billion-dollar BioDefense industry, including BioShield I and BioShield II; the programs of DHS, HHS, NIAID, CDC, FDA, and other agencies; and CBRN detection and response. The Briefings are held quarterly at the National Press Club in Washington.
Dr. George R. Painter, III, President and CEO of Chimerix, Inc, was a speaker and sponsor at the BioDefense Briefing on June 21, 2004.
Dr. Jerome Hauer, Executive Director for the Response to Emergencies and Disasters Institute at George Washington University delivered the keynote address.
Chuck Ludlam, Counsel, Office of Senator Joseph Lieberman, provides a history of Bioshield I and the drafting o f Bioshield II.
Gregory J. Davenport, Ph.D., President, Biodefense Division for DOR BioPharma, Inc., focused on trends and developments in the BioDefense industry.
Sponsors and speakers at the BioDefense Briefing. Frank Rapoport and Dan Jacobs network after the Briefing with speaker Boris Lushniak and William Loiry, sponsor and host of the event.
(There are no refunds. Program
is subject to change.)
The Center for Homeland & Global Security
a division of Equity
International, Inc.
2020 Pennsylvania Avenue, NW, Washington, D.C. 20006, United
States of America